137 related articles for article (PubMed ID: 1689784)
41. Kinetic parameters of 5 alpha-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates.
Bruchovsky N; Rennie PS; Batzold FH; Goldenberg SL; Fletcher T; McLoughlin MG
J Clin Endocrinol Metab; 1988 Oct; 67(4):806-16. PubMed ID: 2458378
[TBL] [Abstract][Full Text] [Related]
42. 5 alpha-reductase activity in stroma and epithelium of rat prostate and epididymis. A contribution to elucidation of the mechanism for development of hyperplastic growth of prostatic tissue.
Djøseland O; Bruchovsky N; Rennie PS; Otal N; Høglo S
Acta Endocrinol (Copenh); 1983 Jun; 103(2):273-81. PubMed ID: 6190338
[TBL] [Abstract][Full Text] [Related]
43. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
[TBL] [Abstract][Full Text] [Related]
44. Non-michaelian behavior of 5 alpha-reductase in human prostate.
Le Goff JM; Martin PM; Ojasoo T; Raynaud JP
J Steroid Biochem; 1989 Aug; 33(2):155-63. PubMed ID: 2475672
[TBL] [Abstract][Full Text] [Related]
45. Androstenedione may be a more important precursor of tissue dihydrotestosterone than testosterone in women.
Silva PD; Gentzschein EE; Lobo RA
Fertil Steril; 1987 Sep; 48(3):419-22. PubMed ID: 3622795
[TBL] [Abstract][Full Text] [Related]
46. In vitro studies on the effect of cofactors on the 5 alpha-reductase and 3 alpha- and 3 beta-hydroxysteroid reductase activities in the hyperplastic human prostate.
Lombardo ME; Hakky SI; Hall MK; Hudson PB
J Urol; 1992 Nov; 148(5):1605-10. PubMed ID: 1279222
[TBL] [Abstract][Full Text] [Related]
47. Testosterone metabolism by homogenates of human prostates with benign hyperplasia: effects of zinc, cadmium and other bivalent cations.
Sinquin G; Morfin RF; Charles JF; Floch HH
J Steroid Biochem; 1984 Mar; 20(3):773-80. PubMed ID: 6200704
[TBL] [Abstract][Full Text] [Related]
48. Stromal 5 alpha-reductase activity is elevated in benign prostatic hyperplasia.
Wilkin RP; Bruchovsky N; Shnitka TK; Rennie PS; Comeau TL
Acta Endocrinol (Copenh); 1980 Jun; 94(2):284-8. PubMed ID: 6158242
[TBL] [Abstract][Full Text] [Related]
49. Androgen concentrations in epithelial and stromal cell nuclei of human benign prostatic hypertrophic tissues.
Lahtonen R; Bolton NJ; Lukkarinen O; Vihko R
J Endocrinol; 1983 Dec; 99(3):409-14. PubMed ID: 6196427
[TBL] [Abstract][Full Text] [Related]
50. Partial purification of human prostatic 5 alpha-reductase (3-oxo-5 alpha-steroid:NADP+ 4-ene-oxido-reductase; EC 1.3.1.22) in a stable and active form.
Sargent NS; Habib FK
J Steroid Biochem Mol Biol; 1991 Jan; 38(1):73-7. PubMed ID: 1705142
[TBL] [Abstract][Full Text] [Related]
51. Effect of aging on kinetic parameters of 5 alpha-reductase in epithelium and stroma of normal and hyperplastic human prostate.
Tunn S; Hochstrate H; Grunwald I; Flüchter SH; Krieg M
J Clin Endocrinol Metab; 1988 Nov; 67(5):979-85. PubMed ID: 2460487
[TBL] [Abstract][Full Text] [Related]
52. 5 Alpha-reductase in the non-secretory cells of the rat ventral prostate epithelium.
Purvis K; Brekke I; Rui H; Sunde A
J Steroid Biochem; 1986 Dec; 25(6):1023-5. PubMed ID: 3795950
[TBL] [Abstract][Full Text] [Related]
53. Androgen metabolism by human prostatic tumours in organ culture.
Smith CB; Masters JR; Metcalfe SA; Ghanadian R
Eur J Cancer Clin Oncol; 1983 Jul; 19(7):929-34. PubMed ID: 6684049
[TBL] [Abstract][Full Text] [Related]
54. Distinct androgen 5 alpha-reduction pathways in cultured fibroblasts and immortalized epithelial cells from normal human adult prostate.
Boudou P; Cussenot O; Sollman H; Villette JM; Teillac P; Le Duc A; Fiet J
J Urol; 1994 Jul; 152(1):226-31. PubMed ID: 8201672
[TBL] [Abstract][Full Text] [Related]
55. Greater conversion of testosterone to 5 alpha-dihydrotestosterone, reflecting increased peripheral 5 alpha-reductase activity in nude mice treated with high doses of cyclosporine A.
Boudou P; Fiet J; Vexiau P; Villette JM; Hardy N; Dreux C
J Steroid Biochem; 1990 Aug; 36(6):597-601. PubMed ID: 2214776
[TBL] [Abstract][Full Text] [Related]
56. C19O2-Steroid transformations in the human normal, hyperplastic and cancerous prostate.
Morfin RF; Charles JF; Floch HH
J Steroid Biochem; 1979 Jul; 11(1B):599-607. PubMed ID: 90752
[No Abstract] [Full Text] [Related]
57. Effects of the anti-androgen finasteride on the modulatory actions of oestradiol on androgen metabolism by human gingival fibroblasts.
Tilakaratne A; Soory M
Arch Oral Biol; 2001 Feb; 46(2):109-15. PubMed ID: 11163318
[TBL] [Abstract][Full Text] [Related]
58. Acute effects of testicular and adrenal cortical blockade on protein synthesis and dihydrotestosterone content of human prostate tissue.
Liu J; Geller J; Albert J; Kirshner M
J Clin Endocrinol Metab; 1985 Jul; 61(1):129-33. PubMed ID: 2581988
[TBL] [Abstract][Full Text] [Related]
59. Epidermal keratinocytes: a source of 5 alpha-dihydrotestosterone production in human skin.
Milewich L; Kaimal V; Shaw CB; Sontheimer
J Clin Endocrinol Metab; 1986 Apr; 62(4):739-46. PubMed ID: 3949953
[TBL] [Abstract][Full Text] [Related]
60. Effect of megestrol acetate (Megace) on steroid metabolism and steroid-protein binding in the human prostate.
Geller J; Albert J; Geller S; Lopez D; Cantor T; Yen S
J Clin Endocrinol Metab; 1976 Nov; 43(5):1000-8. PubMed ID: 62759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
